Cardiac Rhythm Management Devices | Market Insights | Japan | 2021
The mature Japanese CRM device market will remain flat through 2029, characterized by low generator unit volume growth, rising ICM procedure volumes, and price erosion. The uptake of premium-priced devices such as CRT devices, leadless pacemakers, and S-ICDs will help mitigate the downward pressure of reimbursement cuts over the forecast period. However, the COVID-19 global pandemic will have a negative impact on the Japan CRM device market, resulting in lost procedure volumes in the short term followed by a period of recovery.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the Japanese cardiac rhythm management device market across a 10-year period.
